Literature DB >> 24839500

Angiomyolipoma with caval extension and regional nodal involvement: Aggressive behaviour or just rare natural history? Case report and review of literature.

Kamaljot Singh Kaler1, Rebekah Rittberg2, Darrel E Drachenberg1.   

Abstract

Renal angiomyolipoma (AML) is predominantly a non-aggressive benign tumour. Cases of more aggressive AMLs are present in the literature. We present 2 cases of aggressive AML behaviour. The first case is an AML with vascular extension in a young female and the second case is of AML found in regional lymph nodes in a female with a left renal AML and renal cell carcinoma.

Entities:  

Year:  2014        PMID: 24839500      PMCID: PMC4001661          DOI: 10.5489/cuaj.1781

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  15 in total

1.  Benign renal angiomyolipoma with inferior vena cava thrombosis.

Authors:  Varun Mittal; Baldev S Aulakh; Garima Daga
Journal:  Urology       Date:  2011-04-13       Impact factor: 2.649

2.  Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.

Authors:  Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash
Journal:  Urology       Date:  2008-09-21       Impact factor: 2.649

3.  Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.

Authors:  Jay H Ryu; Thomas E Hartman; Vicente E Torres; Paul A Decker
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

Review 4.  The management of renal angiomyolipoma.

Authors:  J E Oesterling; E K Fishman; S M Goldman; F F Marshall
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

5.  Management of angiomyolipoma vena cava thrombus during pregnancy.

Authors:  Jonathan Lopater; Olivier Hartung; Florence Bretelle; Cyrille Bastide
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

6.  Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma.

Authors:  M Pea; F Bonetti; G Martignoni; E P Henske; E Manfrin; C Colato; J Bernstein
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

7.  Epithelioid angiomyolipoma: imaging appearances.

Authors:  N Bharwani; T J Christmas; C Jameson; N Moat; S A Sohaib
Journal:  Br J Radiol       Date:  2009-12       Impact factor: 3.039

8.  Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors.

Authors:  Wenlei He; John C Cheville; Peter M Sadow; Anuradha Gopalan; Samson W Fine; Hikmat A Al-Ahmadie; Ying-Bei Chen; Esther Oliva; Paul Russo; Victor E Reuter; Satish K Tickoo
Journal:  Mod Pathol       Date:  2013-04-19       Impact factor: 7.842

9.  Renal angiomyolipoma with lymph node involvement: a case report and literature review.

Authors:  Wei-Yu Lin; Cheng-Keng Chuang; Kwai-Fong Ng; Shuen-Kuei Liao
Journal:  Chang Gung Med J       Date:  2003-08

10.  Renal angiomyolipoma, fat-poor variant--a clinicopathologic mimicker of malignancy.

Authors:  Vikas Mehta; Girish Venkataraman; Tatjana Antic; Tara C Rubinas; I Caroline Le Poole; Maria M Picken
Journal:  Virchows Arch       Date:  2013-06-01       Impact factor: 4.064

View more
  2 in total

1.  Minimal fat renal angiomyolipoma with lymph node involvement: A case report and literature review.

Authors:  Guangxiang Liu; Dongwei Yao; Shiwei Zhang; Xiaozhi Zhao; Tieshi Liu; Xiaogong Li; Hongqian Guo
Journal:  Can Urol Assoc J       Date:  2015-08-10       Impact factor: 1.862

2.  Renal Angiomyolipoma With Caval Extension and Pulmonary Fat Embolism: A Case Report.

Authors:  Suleyman Utku Celik; Akin Firat Kocaay; Yusuf Sevim; Omer Arda Cetinkaya; Ebru Dusunceli Atman; Iskender Alacayir
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.